SEC
SlamSEC
SearchBrowseEarnings

PHIBRO ANIMAL HEALTH CORP

Nasdaq:PAHC
Pharmaceutical Preparations·TEANECK, NJ
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock.

CEO
Bendheim Jack
CFO
David Glenn
Revenue
$977.9M
+3.8% YoY
FY 2025
Adj. EBITDA
$105.9M
10.8% margin
FY 2025
Net Income
$32.6M
3.3% margin
FY 2025
EPS (Diluted)
$0.81
FY 2025
Stock Price
$50.21
+2.7%
2026-03-11
52W Range
$16.16 – $56.30
P/E Ratio
62.0x
Market Cap
—
Cash
$70.6M
FY 2025
Total Debt
$311.5M
FY 2024
Net Debt
$240.9M
FY 2024
Enterprise Value
—
Debt / EBITDA
2.3x
FY 2025
EV / EBITDA
—
Employees
—